n-Lorem Foundation Partners with Hongene Biotech Corporation to Support the Discovery of Personalized ASO Medicines for Nano-rare Patients
SAN DIEGO, Calif., [...]
World Orphan Drug Congress USA 2024
April 23-25, 2024 - Boston, MA The World Orphan Drug Congress brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers.
Physicians and Institutions Transform the Lives of Nano-rare Patients
with Olivia Kim-McManus, M.D.
n-Lorem Foundation Announces the Second Annual Nano-rare Patient Colloquium Will be Held on Oct. 30 & 31, 2024
This year’s colloquium will [...]
Advanced Genetics Part 2
Understand how [...]
Advanced Genetics Part 1
A SNP [...]
Sharing Hope Through Storytelling & Connection
with Shanna Tolbert
Our Mission is Personal
with Sarah Glass, Ph.D.
Safety and Tolerability of GalNAc3-Conjugated Antisense Drugs Compared to the Same-Sequence 2′-O-Methoxyethyl-Modified Antisense Drugs: Results from an Integrated Assessment of Phase 1 Clinical Trial Data
Baker B.F., Xia, S., Partridge, W., Engelhardt, J.A., Tsimikas, S., Crooke, S.T., Bhanot, S., Geary, R.S. Download PDF
